Gilder Gagnon Howe & Co’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-13,444
| Closed | -$298K | – | 258 |
|
|
2022
Q4 | $298K | Buy |
+13,444
| New | +$298K | 0.01% | 227 |
|
|
2022
Q1 | – | Sell |
-30,983
| Closed | -$736K | – | 341 |
|
|
2021
Q4 | $736K | Sell |
30,983
-126
| -0.4% | -$2.99K | ﹤0.01% | 309 |
|
|
2021
Q3 | $766K | Buy |
31,109
+16,539
| +114% | +$407K | ﹤0.01% | 331 |
|
|
2021
Q2 | $360K | Buy |
14,570
+1,414
| +11% | +$34.9K | ﹤0.01% | 356 |
|
|
2021
Q1 | $287K | Buy |
13,156
+3,361
| +34% | +$73.3K | ﹤0.01% | 333 |
|
|
2020
Q4 | $250K | Sell |
9,795
-33
| -0.3% | -$842 | ﹤0.01% | 296 |
|
|
2020
Q3 | $277K | Sell |
9,828
-172
| -2% | -$4.85K | ﹤0.01% | 296 |
|
|
2020
Q2 | $283K | Buy |
+10,000
| New | +$283K | ﹤0.01% | 267 |
|